Mauricio P. Pinto

2.0k total citations
56 papers, 1.4k citations indexed

About

Mauricio P. Pinto is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Mauricio P. Pinto has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Mauricio P. Pinto's work include Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Cells and Metastasis (7 papers). Mauricio P. Pinto is often cited by papers focused on Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Cells and Metastasis (7 papers). Mauricio P. Pinto collaborates with scholars based in Chile, United States and France. Mauricio P. Pinto's co-authors include Kathryn B. Horwitz, Gareth I. Owen, Carlos Fardella, Lorena Mosso, Celso E. Gómez-Sánchez, Eveline Oestreicher, Britta M. Jacobsen, Luis Miguel Marín Gómez, Álvaro Huete and A Foradori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mauricio P. Pinto

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauricio P. Pinto Chile 20 462 438 391 322 298 56 1.4k
Antonella Verrienti Italy 24 652 1.4× 310 0.7× 1.0k 2.6× 363 1.1× 287 1.0× 74 1.8k
Daisuke Ito Japan 14 573 1.2× 291 0.7× 283 0.7× 163 0.5× 86 0.3× 48 1.2k
Jamal Zidan Israel 23 309 0.7× 518 1.2× 252 0.6× 268 0.8× 205 0.7× 80 1.5k
Xiaoyun Cheng China 21 572 1.2× 590 1.3× 151 0.4× 167 0.5× 198 0.7× 78 1.6k
Thomas Schöndorf Germany 21 590 1.3× 341 0.8× 171 0.4× 126 0.4× 145 0.5× 71 1.4k
Lawrence A. Shirley United States 21 525 1.1× 577 1.3× 199 0.5× 375 1.2× 239 0.8× 48 1.5k
P. Savvides United States 20 455 1.0× 734 1.7× 292 0.7× 285 0.9× 148 0.5× 89 1.7k
Ulrich Marti Switzerland 18 603 1.3× 334 0.8× 248 0.6× 242 0.8× 83 0.3× 41 1.4k
Robert X.-D. Song United States 17 807 1.7× 574 1.3× 286 0.7× 225 0.7× 206 0.7× 19 1.8k
Anny Souque France 21 707 1.5× 408 0.9× 639 1.6× 272 0.8× 318 1.1× 35 1.5k

Countries citing papers authored by Mauricio P. Pinto

Since Specialization
Citations

This map shows the geographic impact of Mauricio P. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio P. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio P. Pinto more than expected).

Fields of papers citing papers by Mauricio P. Pinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauricio P. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio P. Pinto. The network helps show where Mauricio P. Pinto may publish in the future.

Co-authorship network of co-authors of Mauricio P. Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Mauricio P. Pinto. A scholar is included among the top collaborators of Mauricio P. Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauricio P. Pinto. Mauricio P. Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez, César, Irene Cantarero‐Villanueva, Álvaro Reyes, et al.. (2025). Randomized Trial Assessing Prospective Surveillance and Exercise for Preventing Breast Cancer-Related Lymphedema in High-Risk Patients. Archives of Physical Medicine and Rehabilitation. 106(8). 1163–1172. 1 indexed citations
2.
Pinto, Mauricio P., et al.. (2024). CARDIOVASCULAR TOXICITY IN METASTATIC PROSTATE CANCER TREATMENT: BALANCING RISKS, TREATING CONSEQUENCES. European Heart Journal Supplements. 26(Supplement_2). ii180–ii180.
4.
Pinto, Mauricio P., Mónica Cáceres, Franz Villarroel‐Espíndola, et al.. (2024). Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer. Frontiers in Oncology. 14. 1403089–1403089. 9 indexed citations
6.
Acevedo, Francisco, Mauricio Camus, Francisco Domínguez, et al.. (2023). Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients. Breast Cancer Research and Treatment. 199(2). 363–370. 4 indexed citations
7.
Acevedo, Francisco, Gonzalo Martínez, Luigi Gabrielli, et al.. (2022). Oncological Benefit versus Cardiovascular Risk in Breast Cancer Patients Treated with Modern Radiotherapy. Journal of Clinical Medicine. 11(13). 3889–3889. 5 indexed citations
8.
Pinto, Mauricio P., Charlotte Hill, Carolina Sánchez‐Rodríguez, et al.. (2022). Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients. International Journal of Molecular Sciences. 24(1). 1–1. 9 indexed citations
9.
Pinto, Mauricio P., Laura Cereceda, Jose Reyes, et al.. (2022). Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience. Journal of Personalized Medicine. 12(2). 195–195. 2 indexed citations
10.
Püschel, Klaus, Mauricio Camus, María Elena Navarro, et al.. (2021). Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients. Breast Cancer Research and Treatment. 189(2). 561–569. 13 indexed citations
13.
Pinto, Mauricio P., Gonzalo Martínez, Marcelo E. Andía, et al.. (2021). Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol. BMC Cancer. 21(1). 1114–1114. 2 indexed citations
14.
Tran, William T., et al.. (2020). Eribulin-induced radiation recall dermatitis: a case report and brief review of the literature. ecancermedicalscience. 14. 1006–1006. 3 indexed citations
15.
Salas‐Huenuleo, Edison, Marcelo J. Kogan, Mauricio P. Pinto, et al.. (2018). The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat. Journal of Pharmacy and Pharmacology. 71(5). 816–825. 12 indexed citations
16.
Ogba, Ndiya, Nicole Manning, S. Kelly Ambler, et al.. (2014). Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells. Breast Cancer Research. 16(6). 489–489. 50 indexed citations
17.
Harrell, J. Chuck, Wendy W. Dye, Djuana M. E. Harvell, et al.. (2007). Estrogen Insensitivity in a Model of Estrogen Receptor–Positive Breast Cancer Lymph Node Metastasis. Cancer Research. 67(21). 10582–10591. 39 indexed citations
18.
Medina, Rodolfo A., Sumie Kato, Mauricio P. Pinto, et al.. (2007). Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR‐75. Journal of Cellular Physiology. 214(1). 110–116. 29 indexed citations
19.
Kato, Sumie, Mauricio P. Pinto, Anil Sadarangani, et al.. (2005). Progesterone Pre-treatment Potentiates EGF Pathway Signaling in The Breast Cancer Cell Line ZR-75*. Breast Cancer Research and Treatment. 94(2). 171–183. 24 indexed citations
20.
Fardella, Carlos, Lorena Mosso, Celso E. Gómez-Sánchez, et al.. (2000). Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology1. The Journal of Clinical Endocrinology & Metabolism. 85(5). 1863–1867. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026